Billiken Angels Network
VC Fund
St Louis, United States
Billiken Angels Network is a VC fund in St Louis focused on Health Care and Biotechnology. The Billiken Angels Network (BAN) was part of the Entrepreneurship Program of the John Cook School of Business at Saint Louis University. Announced in 2007, it started operating in September 2008 with twenty angels ready to fund suitable opportunities, and a $1,000,000 sidecar co-investment fund made available by the University from its endowment.It closed in September 2017, having made 34 investments in 20 companies.The Billiken Angels’ tag line was “…the deals that make a difference” and that is the goal of the BAN - to identify and invest funds and expertise in those businesses that can make a difference in the economy of the St. Louis region, and in the lives of the people living in the region and elsewhere. The BAN considered businesses at any stage (seed, start-up, existing, growing, etc.) and in any industry (retail, wholesale, manufacturing, service, financial, internet, high-tech, etc.). BAN invested in firms in the St. Louis region, and only considered firms outside of the region when the firm has SLU DNA (firms owned by current or former SLU students, current or retired SLU faculty and staff, or firms using intellectual property licensed from SLU).Membership was open to accredited investors only. All BAN members had a strong commitment to help develop entrepreneurship through education at Saint Louis University in addition to investment.
- Total investments:
- 31
- Last investment:
- Lead investor:
- 10%
Last updated:
For AI agents: llms.txt
Industries Billiken Angels Network invests in
Stages Billiken Angels Network invests in
Countries Billiken Angels Network invests in
Investment Focus
Industry
- Health Care 6 (19%)
- Biotechnology 5 (16%)
- Medical Device 4 (13%)
- Events 3 (10%)
- Mobile 3 (10%)
Stage
- Seed 12 (39%)
- Series A 5 (16%)
- Funding Round 4 (13%)
- Pre-Seed 1 (3%)
- Series C 1 (3%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Geneoscopy
|
Geneoscopy is a non-invasive colorectal cancer diagnostic powered by advanced research in computational biology. The company is determined to replace every patient’s least favorite screen: the colonoscopy. Currently there is no test with high enough specificity and sensitivity to allow patients an alternative to the unpleasant, invasivecolonoscopy. Geneoscopy is changing that.It has developed a novel methodology to reliably and consistently extract human RNA transcripts from stool samples and detect changes in gene expression. This provides Geneoscopy a platform to harness the power of RNA to detect, prevent, and guide treatment for gastrointestinal disease. Geneoscopy is currently developing a diagnostic test for the prevention of colorectal cancer and is conducting research on other applications of its technology for tangential indications. | $1M / Apr 13, 2018 | |
|
Geneoscopy
|
Geneoscopy is a non-invasive colorectal cancer diagnostic powered by advanced research in computational biology. The company is determined to replace every patient’s least favorite screen: the colonoscopy. Currently there is no test with high enough specificity and sensitivity to allow patients an alternative to the unpleasant, invasivecolonoscopy. Geneoscopy is changing that.It has developed a novel methodology to reliably and consistently extract human RNA transcripts from stool samples and detect changes in gene expression. This provides Geneoscopy a platform to harness the power of RNA to detect, prevent, and guide treatment for gastrointestinal disease. Geneoscopy is currently developing a diagnostic test for the prevention of colorectal cancer and is conducting research on other applications of its technology for tangential indications. | $1M / Seed / Apr 13, 2018 | |
Greetabl
|
Greetabl makes it incredibly easy to send unique and personalized gifts that your people will love. In a few clicks, turn your photos into a greeting card that doubles as a gift box. Select from gift cards, chocolates and more to complete your perfect gift (starting at $20!). | $1.5M / Seed / Jun 05, 2017 | |
|
Greetabl
|
Greetabl makes it incredibly easy to send unique and personalized gifts that your people will love. In a few clicks, turn your photos into a greeting card that doubles as a gift box. Select from gift cards, chocolates and more to complete your perfect gift (starting at $20!). | $775K / Seed / Jul 22, 2016 | |
MedAware Solutions
|
The platform is an all-in-one care coordination tool to enable providers, payers, patients and family collaborate across the care continuum. | $2.2M / Mar 25, 2016 | |
Mentor Spaces
|
Mentor Spaces is a mentorship software platform that connects corporate employees to students to support career discovery, navigation and job placement. Used by corporate impact leaders, universities and nonprofits - the platform facilitates career conversations with experts aligned to one’s professional interests and goals. Companies use MentorSpaces to engage employees, cultivate talent pipelines, and improve retention while making measurable social impact. | $1.3M / Seed / Oct 20, 2015 | |
Bonfyre
|
Bonfyre is an enterprise communications platform that is changing the way companies build culture and engage their employees. Our technology brings people together and helps organizations build camaraderie, align culture and drive real-time HR business intelligence. | $147.5K / Seed / Sep 30, 2015 | |
|
Greetabl
|
Greetabl makes it incredibly easy to send unique and personalized gifts that your people will love. In a few clicks, turn your photos into a greeting card that doubles as a gift box. Select from gift cards, chocolates and more to complete your perfect gift (starting at $20!). | Seed / Sep 10, 2015 | |
BookaLokal
|
BookaLokal is a social dining platform that connects hosts and guests through food events around the world. Their events include dinners, brunches, food tours, ice cream tastings, cooking classes and all kinds of creative food events. Their hosts are food bloggers, aspiring chefs, hosting mavens and stay-at-home parents looking to earn money orcover costs while sharing their culinary skills. Their guests are travelers, expats and local people who love food and meeting new people in a culinary setting. | Seed / Jun 15, 2015 | |
Hey Let’s Train
|
Hey Let's Train provides a fan engagement platform to access professional athletes and their training regimens. Creating a new fan-centric service delivery model for sports performance training from top performers from around the world to anytime, anywhere on any device. | $40K / Seed / Jun 05, 2015 | |
| See all 31 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Billiken Angels Network invest in?
Billiken Angels Network invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Seed and Series A stage. Most of the 31 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Billiken Angels Network last invest?
The most recent investment recorded for Billiken Angels Network closed in Apr 2018. Shizune tracks 31 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
